9 studies were found.

1.		Completed	ABX-EGF (a monoclonal antibody) Given to Patients with Prostate Cancer with or without Tumor in Other Parts of the Body Condition: Prostate Cancer
2.		No longer recruiting	ABX-EGF in Combination with Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) Conditions: Carcinoma, Non-Small-Cell Lung Neoplasm; Neoplasm Metastasis; Lung Cancer
3.		No longer recruiting	ENBREL(R) (etanercept) as Treatment for Children with Systemic Onset Juvenile Rheumatoid Arthritis Condition: Juvenile Rheumatoid Arthritis
4.		No longer recruiting	ENBREL(R) (Etanercept) Safety Study in Children with Juvenile Rheumatoid Arthritis Condition: Arthritis, Juvenile Rheumatoid
5.		No longer recruiting	Recombinant Human IL-4 Receptor Used in Treatment of Asthma Condition: Asthma
6.		No longer recruiting	Registry to Evaluate Novantrone (R) Effects in Worsening Multiple Sclerosis (RENEW) Condition: Multiple Sclerosis
7.		Completed	A Research Study in Patients with Renal Cancer to Determine the Safety and Effectiveness of a New Investigational Drug Called ABX-EGF Condition: Renal Cell Carcinoma
8.		Recruiting	Study of Tumor Antigen-Pulsed Autologous Dendritic Cell Vaccination Administrated Subcutaneously or Intranodally Condition: Multiple Myeloma
9.		Terminated	Understanding the Pathogenesis and Treatment of Childhood Onset Dermatomyositis Condition: Dermatomyositis